Loading clinical trials...
Loading clinical trials...
Effectiveness of Electrical Vestibular Nerve Stimulation in the Management of Depression
Trial title: Effectiveness of Electrical Vestibular Nerve Stimulation in the Management of Depression The aim of this study: To better evaluate the efficacy of non-invasive electrical vestibular nerve stimulation (VeNS) as a method of treating Depression, as compared to a sham control. Allocation: Randomized to either active device or control device usage. Endpoint classification: Efficacy Study Intervention Model: Parallel Assignment in 1:1 active to control allocation Sample size: The aim is to recruit a total of up to 60 participants. The study will last 12 weeks in total for each subject.
This double blind randomized controlled trial will enroll up to 60 subjects and will be conducted at the NRI Institute of Medical Sciences. The study will be randomized for a 8-week period with a 1:1 active to sham device allocation. Each participant will complete 5 stimulation sessions per week under the supervision of a researcher at the Department of Physiology. Each session will be 30 minutes on the day of usage. The scheduled study events are to be undertaken at the following timepoints: * Baseline: Study Visit 1 (0-week timepoint for enrolment) * Study Visit 2 (2-week timepoint) * Study Visit 3 (4-week timepoint) * Study Visit 4 (6-week timepoint) * End of Study: Study Visit 5 (8-week timepoint) * Post-intervention follow-up at 4 weeks (12-week timepoint)
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
Yes
NRI Institute of Medical Sciences
Visakhapatnam, Andhra Pradesh, India
Start Date
December 3, 2023
Primary Completion Date
November 5, 2024
Completion Date
November 5, 2024
Last Updated
December 20, 2024
62
ACTUAL participants
Modius Mood Active Device
DEVICE
Sham Device
DEVICE
Lead Sponsor
Neurovalens Ltd.
Collaborators
NCT07360600
NCT06793397
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions